These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12017302)
1. Evidence of a field effect associated with mammary cancer chemoprevention by methylseleninic acid. Dong Y; Ip C; Ganther H Anticancer Res; 2002; 22(1A):27-32. PubMed ID: 12017302 [TBL] [Abstract][Full Text] [Related]
2. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Ip C; Thompson HJ; Ganther HE Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463 [TBL] [Abstract][Full Text] [Related]
3. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Ip C; Dong Y Anticancer Res; 2001; 21(2A):863-7. PubMed ID: 11396176 [TBL] [Abstract][Full Text] [Related]
4. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray. El-Bayoumy K; Narayanan BA; Desai DH; Narayanan NK; Pittman B; Amin SG; Schwartz J; Nixon DW Carcinogenesis; 2003 Sep; 24(9):1505-14. PubMed ID: 12844480 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Ip C; Thompson HJ; Zhu Z; Ganther HE Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic. Dong Y; Lisk D; Block E; Ip C Cancer Res; 2001 Apr; 61(7):2923-8. PubMed ID: 11306469 [TBL] [Abstract][Full Text] [Related]
7. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor. Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Ip C; Ip MM; Loftus T; Shoemaker S; Shea-Eaton W Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):689-96. PubMed ID: 10919739 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. El-Bayoumy K; Sinha R Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592 [TBL] [Abstract][Full Text] [Related]
10. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Dong Y; Zhang H; Hawthorn L; Ganther HE; Ip C Cancer Res; 2003 Jan; 63(1):52-9. PubMed ID: 12517777 [TBL] [Abstract][Full Text] [Related]
11. Molecular chemoprevention by selenium: a genomic approach. El-Bayoumy K; Sinha R Mutat Res; 2005 Dec; 591(1-2):224-36. PubMed ID: 16099479 [TBL] [Abstract][Full Text] [Related]
12. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. El-Bayoumy K; Das A; Narayanan B; Narayanan N; Fiala ES; Desai D; Rao CV; Amin S; Sinha R Carcinogenesis; 2006 Jul; 27(7):1369-76. PubMed ID: 16399772 [TBL] [Abstract][Full Text] [Related]
13. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Ip C; Lisk DJ; Ganther HE Anticancer Res; 1998; 18(6A):4019-25. PubMed ID: 9891440 [TBL] [Abstract][Full Text] [Related]
14. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Ip C; Lisk DJ; Ganther H; Thompson HJ Anticancer Res; 1997; 17(5A):3195-9. PubMed ID: 9413148 [TBL] [Abstract][Full Text] [Related]
15. Effect of dietary energy restriction on vascular density during mammary carcinogenesis. Thompson HJ; McGinley JN; Spoelstra NS; Jiang W; Zhu Z; Wolfe P Cancer Res; 2004 Aug; 64(16):5643-50. PubMed ID: 15313902 [TBL] [Abstract][Full Text] [Related]
16. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
17. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045 [TBL] [Abstract][Full Text] [Related]
18. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. Moral R; Wang R; Russo IH; Lamartiniere CA; Pereira J; Russo J J Endocrinol; 2008 Jan; 196(1):101-12. PubMed ID: 18180321 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. Swede H; Dong Y; Reid M; Marshall J; Ip C Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1248-52. PubMed ID: 14652289 [TBL] [Abstract][Full Text] [Related]
20. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]